These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 33228590)

  • 21. An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
    Cao R; Ma B; Wang G; Xiong Y; Tian Y; Yuan L
    Dis Markers; 2020; 2020():8833972. PubMed ID: 33204364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
    Chen Q; Tang P; Huang H; Qiu X
    Front Immunol; 2022; 13():934124. PubMed ID: 35958575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
    Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
    Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
    Wang X; Xing Z; Xu H; Yang H; Xing T
    Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
    Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
    Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
    Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
    Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
    Zhu G; Xia H; Tang Q; Bi F
    Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
    Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
    BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
    Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
    Front Oncol; 2022; 12():974614. PubMed ID: 36185284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
    Pichler M; Ress AL; Winter E; Stiegelbauer V; Karbiener M; Schwarzenbacher D; Scheideler M; Ivan C; Jahn SW; Kiesslich T; Gerger A; Bauernhofer T; Calin GA; Hoefler G
    Br J Cancer; 2014 Mar; 110(6):1614-21. PubMed ID: 24504363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An EMT-related gene signature for the prognosis of human bladder cancer.
    Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
    J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
    Tong H; Li T; Gao S; Yin H; Cao H; He W
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 38. Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer.
    Mo S; Dai W; Zhou Z; Gu R; Li Y; Xiang W; Han L; Zhang L; Wang R; Cai G; Cai S; Gan L; Li Q
    Front Cell Dev Biol; 2021; 9():681431. PubMed ID: 34211976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
    Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
    Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of 14-gene signature prognostic model based on metastasis for colorectal cancer.
    Li T; Yu Q; Liu T; Yang W; Chen W; Jin A; Wang H; Ding L; Zhang C; Pan B; Wang B; Guo W
    J Clin Lab Anal; 2023 Jan; 37(1):e24800. PubMed ID: 36524971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.